JOHN D. KRIESEL, MD
Osteopathic Medicine at Medical Dr, Salt Lake City, UT
License number
Utah 181533-1205
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
50 N Medical Dr, Salt Lake City, UT 84132
Phone
(801) 585-2031
(801) 213-3800
(801) 213-3800
Personal information
See more information about JOHN D. KRIESEL at radaris.comName
Address
Phone
4554 Kayland Cir, Salt Lake Cty, UT 84117
4554 Kayland Cir, Holladay, UT 84117
3656 2245Th A, Salt Lake City, UT 84109
3656 2245 E, Salt Lake City, UT 84109
Professional information
John D Kriesel, Salt Lake City UT
Specialties:
Infectious Disease Specialist
Address:
50 N Medical Dr, Salt Lake City, UT 84132
Education:
Washington University, School of Medicine - Doctor of Medicine
University Health Care - Fellowship - Infectious Disease (Internal Medicine)
University Health Care - Residency - Internal Medicine
University Health Care - Fellowship - Infectious Disease (Internal Medicine)
University Health Care - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)
Associate Professor At University Of Utah Hospital
Position:
Associate Professor at University of Utah Hospital
Location:
Greater Salt Lake City Area
Industry:
Medical Practice
Work:
University of Utah Hospital
-
Associate Professor
John D Kriesel, Salt Lake City UT
Specialties:
Internal Medicine, Infectious Disease, Preventive Medicine
Work:
Uumc Infectious Disease
50 N Medical Dr, Salt Lake City, UT 84132 Uuhc Redwood Health Center
1525 W 2100 S, Salt Lake City, UT 84119 Va Salt Lake City Health Care System
500 Foothill Dr, Salt Lake City, UT 84148 School of Medicine
30 N Medical Dr, Salt Lake City, UT 84132
50 N Medical Dr, Salt Lake City, UT 84132 Uuhc Redwood Health Center
1525 W 2100 S, Salt Lake City, UT 84119 Va Salt Lake City Health Care System
500 Foothill Dr, Salt Lake City, UT 84148 School of Medicine
30 N Medical Dr, Salt Lake City, UT 84132
Education:
Washington University at St. Louis (1988)
Diagnosis And Treatment Of Herpes Simplex Virus Diseases
US Patent:
7449294, Nov 11, 2008
Filed:
Apr 11, 2005
Appl. No.:
11/102978
Inventors:
John D. Kriesel - Holladay UT, US
Mark F. Leppert - Salt Lake City UT, US
Brith E. M. Otterud - Salt Lake City UT, US
Maurine R. Hobbs - Salt Lake City UT, US
Brandt B. Jones - Bountiful UT, US
Mark F. Leppert - Salt Lake City UT, US
Brith E. M. Otterud - Salt Lake City UT, US
Maurine R. Hobbs - Salt Lake City UT, US
Brandt B. Jones - Bountiful UT, US
Assignee:
University of Utah Research Foundation - Salt Lake City UT
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The invention maps a herpes simplex labialis (HSL) susceptibility gene associated with HSL to the q11 region of chromosome 21. The invention provides methods of screening for susceptibility or resistance to herpes simplex virus, particularly herpes simplex labialis, and diagnosing herpetic diseases, such as HSL.
Oligonucleotide Complexes For Use As Anti-Viral Therapeutics
US Patent:
2005003, Feb 17, 2005
Filed:
Apr 21, 2004
Appl. No.:
10/830287
Inventors:
John Kriesel - Holladay UT, US
Brandt Jones - Bountiful UT, US
Charles Grissom - Salt Lake City UT, US
Geoff Herpin - Salt Lake City UT, US
Peter Glazer - Guilford CT, US
Brandt Jones - Bountiful UT, US
Charles Grissom - Salt Lake City UT, US
Geoff Herpin - Salt Lake City UT, US
Peter Glazer - Guilford CT, US
International Classification:
C07K001/00, C07K017/00, C07H021/04, C12N007/01, A01N047/28, C12N007/00, C12N015/74, A61K031/17
US Classification:
536023720, 530350000, 536024330, 536024100, 435235100, 435320100
Abstract:
The methods disclosed herein are of use for the treatment of a wide variety of diseases. In particular, the methods provide for the targeting of a transcription altering agent to a specific target site of a viral genome in order to inactivate the virus. In addition, the methods provide for a triplex-forming oligonucleotide capable of interacting with a target site in a viral genome in order to alter transcription. The methods of the present invention may be used against viral pathogens or agents of bioterrorism.